Clinical trial
Identifying Molecular Alterations to Guide Individualized Treatment in Advanced Solid Tumors-PERMED01-IPC 2014-003
NCT02342158 is registered in ClinicalTrials.gov with Institut Paoli-Calmettes as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Identifying Molecular Alterations to Guide Individualized Treatment in Advanced Solid Tumors-PERMED01-IPC 2014-003
- Lead sponsor
- Institut Paoli-Calmettes
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 12, 2014
- Completion date
- August 18, 2022
- Enrollment
- 550 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.